Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 5, 1997, Pages 989-995

  Verhoef, Petra ^a   Kok, Frans J ^a   Kruyssen, Dick A C M ^b   Schouten, Evert G ^a   Witteman, Jacqueline C M ^c   Grobbee, Diederick E ^c   Ueland, Per M ^d   Refsum, Helga ^d  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Zuiderziekenhuis   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

coronary atherosclerosis; plasma total homocysteine; risk factor; vitamins

Indexed keywords

CHOLESTEROL; CYANOCOBALAMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 0030994488     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.5.989     Document Type: Article

References (13)

1. Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr, ed. Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. New York, NY: Marcel Dekker, Inc; 1992:183-236.
2. 6, and folate on blood homocysteine levels. Amt N Y Acad Sci. 1992;30:197-204.
3. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698.
4. Brattström L, Israelsson B, Norrving B, Bergqvist D, Thörne J, Hultberg B, Hamfelt A. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Atherosclerosis. 1990;81:51-60.
5. Malinow MR. Homocyst(e)ine and arterial occlusive diseases: a mini review. Clin Chem. 1994;40:173-176.
6. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049-1057.
7. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest. 1976;57:1079-1082.
8. Kang SS, Wong PW, Cook HY, Norusis M, Messer JV. Protein-bound homocyst(e)ine: a possible risk factor for coronary artery disease. J Clín Invest. 1986;77:1482-1486.
9. Genest JJ Jr, McNamara JR, Salem DN, Wilson PW, Schaefer EJ, Malinow MR. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol. 1990;16: 1114-1119.
10. Ubbink JB, Vermaak WHJ, Bennett JM, Becker PJ, Van Staden DA, Bissbort S. The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease. Klin Wochenschr. 1991;69:527-534.
11. 12 concentrations and risk of early-onset coronary artery disease. Am J Clin Nutr. 1994;59:940-948.
12. Von Eckardstein A, Malinow MR, Upson B, Heinrich J, Schulte H, Schönfeld R, Köhler E, Assmann G. Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men. Arterioscler Thromb. 1994;14:460-464.
13. 6, pyridoxal phosphate, and folate. Am J Cardiol. 1995;75:1107-1111.